(S)-nicotine increases expression EXP 6480464 Nicotine results in increased expression of MSX1 mRNA CTD PMID:20339300 1-[(4-chlorophenyl)-phenylmethyl]-4-methylpiperazine increases expression EXP 6480464 chlorcyclizine results in increased expression of MSX1 mRNA CTD PMID:21058326 17beta-estradiol increases expression ISO RGD:731562 6480464 Estradiol results in increased expression of MSX1 mRNA CTD PMID:31614463 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:731563 6480464 Tetrachlorodibenzodioxin affects the expression of MSX1 mRNA CTD PMID:24058054 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:731563 6480464 Tetrachlorodibenzodioxin results in decreased expression of MSX1 mRNA CTD PMID:16922920 more ... 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:731563 6480464 Tetrachlorodibenzodioxin promotes the reaction [tributyltin results in decreased expression of MSX1 mRNA] CTD PMID:22749964 4,4'-sulfonyldiphenol increases expression ISO RGD:731563 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of MSX1 mRNA CTD PMID:30951980 5-aza-2'-deoxycytidine increases expression ISO RGD:731562 6480464 Decitabine results in increased expression of MSX1 mRNA CTD PMID:16367923 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of MSX1 mRNA CTD PMID:25825206 acrylamide decreases expression ISO RGD:731563 6480464 Acrylamide results in decreased expression of MSX1 mRNA CTD PMID:35032568 aflatoxin B1 affects expression ISO RGD:731562 6480464 Aflatoxin B1 affects the expression of MSX1 protein CTD PMID:20106945 all-trans-retinoic acid increases expression ISO RGD:731563 6480464 Tretinoin results in increased expression of MSX1 mRNA CTD PMID:16604517 all-trans-retinoic acid increases expression ISO RGD:731562 6480464 Tretinoin results in increased expression of MSX1 mRNA CTD PMID:17138961 , PMID:21934132 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of MSX1 mRNA CTD PMID:16483693 antirheumatic drug increases expression ISO RGD:731562 6480464 Antirheumatic Agents results in increased expression of MSX1 mRNA CTD PMID:24449571 aristolochic acid A increases expression ISO RGD:731562 6480464 aristolochic acid I results in increased expression of MSX1 mRNA CTD PMID:33212167 arsane increases methylation ISO RGD:731562 6480464 Arsenic results in increased methylation of MSX1 promoter CTD PMID:21291286 arsenic atom increases methylation ISO RGD:731562 6480464 Arsenic results in increased methylation of MSX1 promoter CTD PMID:21291286 arsenite(3-) increases methylation ISO RGD:731562 6480464 arsenite results in increased methylation of MSX1 promoter CTD PMID:23974009 belinostat increases expression ISO RGD:731562 6480464 belinostat results in increased expression of MSX1 mRNA CTD PMID:26272509 belinostat multiple interactions ISO RGD:731562 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MSX1 mRNA CTD PMID:27188386 benzo[a]pyrene affects methylation ISO RGD:731562 6480464 Benzo(a)pyrene affects the methylation of MSX1 promoter CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:731562 6480464 Benzo(a)pyrene results in decreased expression of MSX1 mRNA CTD PMID:30659931 bis(2-ethylhexyl) phthalate increases expression ISO RGD:731562 6480464 Diethylhexyl Phthalate results in increased expression of MSX1 mRNA CTD PMID:28412506 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:731562 6480464 Diethylhexyl Phthalate results in decreased expression of MSX1 mRNA CTD PMID:31163220 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of MSX1 mRNA CTD PMID:25181051 bisphenol A increases methylation ISO RGD:731562 6480464 bisphenol A results in increased methylation of MSX1 gene CTD PMID:31601247 bisphenol A increases expression ISO RGD:731563 6480464 bisphenol A results in increased expression of MSX1 mRNA CTD PMID:30951980 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of MSX1 mRNA CTD PMID:30816183 , PMID:34947998 bisphenol A affects methylation ISO RGD:731563 6480464 bisphenol A affects the methylation of MSX1 promoter CTD PMID:27334623 bisphenol F increases expression ISO RGD:731563 6480464 bisphenol F results in increased expression of MSX1 mRNA CTD PMID:30951980 cannabidiol decreases expression ISO RGD:731562 6480464 Cannabidiol results in decreased expression of MSX1 mRNA CTD PMID:27918106 carbamazepine affects expression ISO RGD:731562 6480464 Carbamazepine affects the expression of MSX1 mRNA CTD PMID:25979313 choline multiple interactions ISO RGD:731563 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of MSX1 gene CTD PMID:20938992 copper atom increases expression EXP 6480464 Copper results in increased expression of MSX1 mRNA CTD PMID:30556269 copper(0) increases expression EXP 6480464 Copper results in increased expression of MSX1 mRNA CTD PMID:30556269 copper(II) sulfate increases expression ISO RGD:731562 6480464 Copper Sulfate results in increased expression of MSX1 mRNA CTD PMID:19549813 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of MSX1 mRNA CTD PMID:26577399 cyclosporin A increases expression ISO RGD:731562 6480464 Cyclosporine results in increased expression of MSX1 mRNA CTD PMID:20106945 cyproconazole decreases expression ISO RGD:731563 6480464 cyproconazole results in decreased expression of MSX1 mRNA CTD PMID:22045034 cytarabine decreases expression ISO RGD:731562 6480464 Cytarabine results in decreased expression of MSX1 mRNA CTD PMID:21198554 DDT decreases expression EXP 6480464 DDT results in decreased expression of MSX1 mRNA CTD PMID:19797855 dimethylarsinous acid decreases expression ISO RGD:731563 6480464 dimethylarsinous acid results in decreased expression of MSX1 protein CTD PMID:26024302 diuron decreases expression EXP 6480464 Diuron results in decreased expression of MSX1 mRNA CTD PMID:25152437 dorsomorphin multiple interactions ISO RGD:731562 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:731562 6480464 Doxorubicin results in decreased expression of MSX1 mRNA CTD PMID:29803840 entinostat increases expression ISO RGD:731562 6480464 entinostat results in increased expression of MSX1 mRNA CTD PMID:26272509 flavonoids increases expression EXP 6480464 Flavonoids results in increased expression of MSX1 mRNA CTD PMID:18035473 folic acid multiple interactions ISO RGD:731563 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of MSX1 gene CTD PMID:20938992 formaldehyde increases expression ISO RGD:731562 6480464 Formaldehyde results in increased expression of MSX1 mRNA CTD PMID:20655997 furan decreases expression EXP 6480464 furan results in decreased expression of MSX1 mRNA CTD PMID:25539665 glycidol increases expression EXP 6480464 glycidol results in increased expression of MSX1 mRNA CTD PMID:24395379 hexaconazole decreases expression ISO RGD:731563 6480464 hexaconazole results in decreased expression of MSX1 mRNA CTD PMID:22045034 L-methionine multiple interactions ISO RGD:731563 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of MSX1 gene CTD PMID:20938992 Licochalcone B increases expression ISO RGD:731562 6480464 licochalcone B results in increased expression of MSX1 mRNA CTD PMID:33647349 mercury dibromide increases expression ISO RGD:731562 6480464 mercuric bromide results in increased expression of MSX1 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:731562 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MSX1 mRNA CTD PMID:27188386 nicotine increases expression EXP 6480464 Nicotine results in increased expression of MSX1 mRNA CTD PMID:20339300 ozone multiple interactions ISO RGD:731563 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of MSX1 mRNA CTD PMID:34911549 p-chloromercuribenzoic acid increases expression ISO RGD:731562 6480464 p-Chloromercuribenzoic Acid results in increased expression of MSX1 mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO RGD:731562 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MSX1 mRNA CTD PMID:27188386 panobinostat multiple interactions ISO RGD:731562 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MSX1 mRNA CTD PMID:27188386 panobinostat increases expression ISO RGD:731562 6480464 panobinostat results in increased expression of MSX1 mRNA CTD PMID:26272509 paracetamol increases expression ISO RGD:731562 6480464 Acetaminophen results in increased expression of MSX1 mRNA CTD PMID:21420995 , PMID:29067470 phenobarbital affects expression ISO RGD:731562 6480464 Phenobarbital affects the expression of MSX1 mRNA CTD PMID:19159669 phenylmercury acetate increases expression ISO RGD:731562 6480464 Phenylmercuric Acetate results in increased expression of MSX1 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:731562 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MSX1 mRNA CTD PMID:27188386 quercetin decreases expression ISO RGD:731562 6480464 Quercetin results in decreased expression of MSX1 mRNA CTD PMID:21632981 quercetin decreases expression EXP 6480464 Quercetin results in decreased expression of MSX1 protein CTD PMID:28431985 retinyl acetate increases expression ISO RGD:731563 6480464 retinol acetate results in increased expression of MSX1 mRNA CTD PMID:16772331 SB 431542 multiple interactions ISO RGD:731562 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silver atom increases expression ISO RGD:731562 6480464 Silver results in increased expression of MSX1 mRNA CTD PMID:26551752 silver atom increases expression ISO RGD:731563 6480464 Silver results in increased expression of MSX1 mRNA CTD PMID:27131904 silver(0) increases expression ISO RGD:731562 6480464 Silver results in increased expression of MSX1 mRNA CTD PMID:26551752 silver(0) increases expression ISO RGD:731563 6480464 Silver results in increased expression of MSX1 mRNA CTD PMID:27131904 sodium arsenite multiple interactions ISO RGD:731562 6480464 monoisoamyl-2, 3-dimercaptosuccinate inhibits the reaction [sodium arsenite results in decreased expression of MSX1 mRNA] CTD PMID:19615344 sodium arsenite decreases expression ISO RGD:731563 6480464 sodium arsenite results in decreased expression of MSX1 mRNA, sodium arsenite results in decreased expression of MSX1 protein CTD PMID:26024302 sodium arsenite decreases expression ISO RGD:731562 6480464 sodium arsenite results in decreased expression of MSX1 mRNA CTD PMID:19615344 , PMID:34032870 sulindac sulfide decreases expression ISO RGD:731562 6480464 sulindac sulfide results in decreased expression of MSX1 mRNA, sulindac sulfide results in decreased expression of MSX1 protein CTD PMID:12734198 temozolomide increases expression ISO RGD:731562 6480464 Temozolomide results in increased expression of MSX1 mRNA CTD PMID:31758290 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of MSX1 mRNA CTD PMID:34492290 tributylstannane multiple interactions ISO RGD:731563 6480464 Tetrachlorodibenzodioxin promotes the reaction [tributyltin results in decreased expression of MSX1 mRNA] CTD PMID:22749964 tributylstannane decreases expression ISO RGD:731563 6480464 tributyltin results in decreased expression of MSX1 mRNA CTD PMID:22749964 trichostatin A increases expression ISO RGD:731562 6480464 trichostatin A results in increased expression of MSX1 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:731562 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MSX1 mRNA CTD PMID:27188386 trimellitic anhydride decreases expression ISO RGD:731563 6480464 trimellitic anhydride results in decreased expression of MSX1 mRNA CTD PMID:19042947 troglitazone increases expression ISO RGD:731562 6480464 troglitazone results in increased expression of MSX1 mRNA CTD PMID:19140230 urethane increases expression ISO RGD:731562 6480464 Urethane results in increased expression of MSX1 mRNA CTD PMID:28818685 valproic acid decreases expression ISO RGD:731563 6480464 Valproic Acid results in decreased expression of MSX1 mRNA CTD PMID:19136453 , PMID:22045034 valproic acid decreases expression ISO RGD:731562 6480464 Valproic Acid results in decreased expression of MSX1 mRNA CTD PMID:28001369 valproic acid multiple interactions ISO RGD:731562 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MSX1 mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:731562 6480464 Valproic Acid results in increased expression of MSX1 mRNA CTD PMID:23179753 more ... valproic acid affects expression ISO RGD:731562 6480464 Valproic Acid affects the expression of MSX1 mRNA CTD PMID:25979313 vorinostat increases expression ISO RGD:731562 6480464 vorinostat results in increased expression of MSX1 mRNA CTD PMID:26272509 vorinostat multiple interactions ISO RGD:731562 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MSX1 mRNA CTD PMID:27188386 zinc atom multiple interactions ISO RGD:731562 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of MSX1 mRNA CTD PMID:18593933 zinc(0) multiple interactions ISO RGD:731562 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of MSX1 mRNA CTD PMID:18593933